Correction to: Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial

Mark A Moyad; Larry E Robinson; Julie M Kittelsrud; Stuart G Reeves; Susan E Weaver; Aireen I Guzman; Mark E Bubak

doi:10.1007/s12325-019-00996-5

Correction to: Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial

Adv Ther. 2019 Aug;36(8):2191. doi: 10.1007/s12325-019-00996-5.

Authors

Mark A Moyad¹, Larry E Robinson², Julie M Kittelsrud³, Stuart G Reeves⁴, Susan E Weaver³, Aireen I Guzman⁵, Mark E Bubak⁶

Affiliations

¹ University of Michigan Medical Center, Department of Urology, Ann Arbor, Michigan, 48109-0330, USA. moyad@umich.edu.
² Vice President, Scientific Affairs, Embria Health Sciences, Ankeny, Iowa, USA.
³ Nurse Practitioner, Avera Research Institute, Sioux Falls, South Dakota, USA.
⁴ Director of Research and Development, Embria Health Sciences, Ankeny, Iowa, USA.
⁵ Statistical Consultant, Avera Research Institute, Sioux Falls, South Dakota, USA.
⁶ Assistant Professor, Allergy, Department of Internal Medicine, USD Sanford School of Medicine, Sioux Falls, South Dakota, USA.

Abstract

The article ''Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial'', written by Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud, Stuart G. Reeves, Susan E. Weaver, Aireen I. Guzman, Mark E. Bubak was originally published electronically on the publisher's internet portal (currently Springer-Link) on 12 August, 2009.

Publication types

Published Erratum